[Symptomatic therapeutic effect of cycrimine HCl in parkinsonian syndromes].
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders; D010880:Piperidines
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D010880:Piperidines; C012262:cycrimine
MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy
Action thérapeutique symptomatique du chlorhydrate de cycrimine sur les syndromes parkinsoniens.